Effect of intravenous amino acids on interdigestive antroduodenal motility and small bowel transit time
- PMID: 9895384
- PMCID: PMC1727372
- DOI: 10.1136/gut.44.2.240
Effect of intravenous amino acids on interdigestive antroduodenal motility and small bowel transit time
Abstract
Background: Patients on total parenteral nutrition have an increased risk of developing gallstones because of gall bladder hypomotility. High dose amino acids may prevent biliary stasis by stimulating gall bladder emptying.
Aims: To investigate whether intravenous amino acids also influence antroduodenal motility.
Methods: Eight healthy volunteers received, on three separate occasions, intravenous saline (control), low dose amino acids (LDA), or high dose amino acids (HDA). Antroduodenal motility was recorded by perfusion manometry and duodenocaecal transit time (DCTT) using the lactulose breath hydrogen test.
Results: DCTT was significantly prolonged during LDA and HDA treatment compared with control. The interdigestive motor pattern was maintained and migrating motor complex (MMC) cycle length was significantly reduced during HDA compared with control and LDA due to a significant reduction in phase II duration. Significantly fewer phase IIIs originated in the gastric antrum during LDA and HDA compared with control. Duodenal phase II motility index was significantly reduced during HDA, but not during LDA, compared with control.
Conclusions: Separate intravenous infusion of high doses of amino acids in healthy volunteers: (1) modulates interdigestive antroduodenal motility; (2) shortens MMC cycle length due to a reduced duration of phase II with a lower contractile incidence both in the antrum and duodenum (phase I remains unchanged whereas the effect on phase III is diverse: in the antrum phase III is suppressed and in the duodenum the frequency is increased); and (3) prolongs interdigestive DCTT.
Figures



Similar articles
-
Is the effect of acute hyperglycaemia on interdigestive antroduodenal motility and small-bowel transit mediated by insulin?Eur J Clin Invest. 1997 Aug;27(8):703-10. doi: 10.1046/j.1365-2362.1997.1680723.x. Eur J Clin Invest. 1997. PMID: 9279536 Clinical Trial.
-
Interdigestive antroduodenal motility and gastric acid secretion.Aliment Pharmacol Ther. 1998 Jan;12(1):27-33. doi: 10.1046/j.1365-2036.1998.00267.x. Aliment Pharmacol Ther. 1998. PMID: 9692697 Clinical Trial.
-
Effects of medium-chain and long-chain triglycerides on antroduodenal motility and small bowel transit time in man.Dig Dis Sci. 1997 Sep;42(9):1933-9. doi: 10.1023/a:1018823512901. Dig Dis Sci. 1997. PMID: 9331158
-
The effects of general anaesthesia on antroduodenal motility, gastric pH and gastric emptying in man.Dan Med Bull. 1991 Aug;38(4):347-65. Dan Med Bull. 1991. PMID: 1914534 Review.
-
Antroduodenal manometry: an evaluation of an emerging methodology.Dig Dis. 1997;15 Suppl 1:53-63. doi: 10.1159/000171621. Dig Dis. 1997. PMID: 9177945 Review.
Cited by
-
Pathogenesis of tropical sprue: a pilot study of antroduodenal manometry, duodenocaecal transit time & fat-induced ileal brake.Indian J Med Res. 2013 Jan;137(1):63-72. Indian J Med Res. 2013. PMID: 23481053 Free PMC article.
-
Effect of intraduodenal and intravenous amino acids on proximal gastric motor function in man.Dig Dis Sci. 2001 Jan;46(1):38-45. doi: 10.1023/a:1005649506525. Dig Dis Sci. 2001. PMID: 11270792
-
Gastric stimulation in the digestive period modifies length and contractility of the inter-digestive period in obese non-diabetic and diabetic subjects.Obes Surg. 2012 Sep;22(9):1465-72. doi: 10.1007/s11695-012-0703-3. Obes Surg. 2012. PMID: 22761022 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources